The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

AC1NSFHW     (6R,7S)-7-[[(2E)-2-(2-amino- 1,3-thiazol-4...

Synonyms: CHEMBL551654, BIDD:GT0710, AKOS015896629, FT-0603017, I06-2290
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of ceftizoxime


High impact information on ceftizoxime


Chemical compound and disease context of ceftizoxime


Biological context of ceftizoxime


Anatomical context of ceftizoxime


Associations of ceftizoxime with other chemical compounds


Gene context of ceftizoxime


Analytical, diagnostic and therapeutic context of ceftizoxime


  1. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Meyer, K.S., Urban, C., Eagan, J.A., Berger, B.J., Rahal, J.J. Ann. Intern. Med. (1993) [Pubmed]
  2. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods. Moody, J.A., Gerding, D.N., Peterson, L.R. Am. J. Med. (1987) [Pubmed]
  3. In vitro activity of cefotetan compared with that of other antimicrobial agents against anaerobic bacteria. Wexler, H.M., Finegold, S.M. Antimicrob. Agents Chemother. (1988) [Pubmed]
  4. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice. Brook, I. J. Infect. Dis. (1989) [Pubmed]
  5. Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Richards, D.M., Heel, R.C. Drugs (1985) [Pubmed]
  6. Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis. Gross, M.L., Somani, P., Ribner, B.S., Raeader, R., Freimer, E.H., Higgins, J.T. Clin. Pharmacol. Ther. (1983) [Pubmed]
  7. Structure-activity relationships related to ceftizoxime (FK 749). Nakano, H. Medicinal research reviews. (1981) [Pubmed]
  8. Comparative study of the effects of ceftizoxime, piperacillin, and piperacillin-tazobactam concentrations on antibacterial activity and selection of antibiotic-resistant mutants of Enterobacter cloacae and Bacteroides fragilis in vitro and in vivo in mixed-infection abscesses. Stearne, L.E., van Boxtel, D., Lemmens, N., Goessens, W.H., Mouton, J.W., Gyssens, I.C. Antimicrob. Agents Chemother. (2004) [Pubmed]
  9. Population pharmacokinetics of ceftizoxime administered by continuous infusion in clinically ill adult patients. Facca, B., Frame, B., Triesenberg, S. Antimicrob. Agents Chemother. (1998) [Pubmed]
  10. Comparison of antibiotic activities by using serum bactericidal activity over time. Guglielmo, B.J., Rodondi, L.C. Antimicrob. Agents Chemother. (1988) [Pubmed]
  11. Canadian Multicenter Susceptibility Study, with a focus on cephalosporins, from 15 Canadian medical centers. The Canadian Multicenter Study Group. Blondeau, J.M., Yaschuk, Y. Antimicrob. Agents Chemother. (1997) [Pubmed]
  12. Delayed cerebrospinal fluid sterilization in infants with Hemophilus influenzae type b meningitis. Hatch, D.L., Overturf, G.D. J. Infect. Dis. (1989) [Pubmed]
  13. Differences between ceftizoxime and its stereoisomer in antibacterial activity and affinity for penicillin-binding proteins. Shigi, Y., Kojo, H., Wakasugi, M., Nishida, M. Antimicrob. Agents Chemother. (1981) [Pubmed]
  14. In vitro activity and beta-lactamase stability of cefmenoxime. Neu, H.C., Labthavikul, P. Antimicrob. Agents Chemother. (1982) [Pubmed]
  15. Ceftizoxime kinetics and renal handling. Dubb, J., Actor, P., Pitkin, D., Alexander, F., Familiar, R., Ehrlich, S., Stote, R. Clin. Pharmacol. Ther. (1982) [Pubmed]
  16. Pharmacokinetics, protein binding, and extravascular distribution of ceftizoxime in normal subjects. Peterson, L.R., Gerding, D.N., Van Etta, L.L., Eckfeldt, J.H., Larson, T.A. Antimicrob. Agents Chemother. (1982) [Pubmed]
  17. Forecasting cephalosporin and monobactam antibiotic half-lives in humans from data collected in laboratory animals. Mordenti, J. Antimicrob. Agents Chemother. (1985) [Pubmed]
  18. beta-Lactam resistance in Serratia marcescens: comparison of action of benzylpenicillin, Apalcillin, Cefazolin, and ceftizoxime. Takata, N., Suginaka, H., Kotani, S., Ogawa, M., Kosaki, G. Antimicrob. Agents Chemother. (1981) [Pubmed]
  19. Differential stimulation of lymphocyte cell growth in vitro by cephalosporins. Leyhausen, G., Seibert, G., Maidhof, A., Müller, W.E. Antimicrob. Agents Chemother. (1984) [Pubmed]
  20. Treatment of bacterial meningitis with ceftizoxime. Overturf, G.D., Cable, D.C., Forthal, D.N., Shikuma, C. Antimicrob. Agents Chemother. (1984) [Pubmed]
  21. Double-blind comparison of cefazolin and ceftizoxime for prophylaxis against infections following elective biliary tract surgery. Jewesson, P.J., Stiver, G., Wai, A., Frighetto, L., Nickoloff, D., Smith, J., Schwartz, L., Sleigh, K., Danforth, D., Scudamore, C., Chow, A. Antimicrob. Agents Chemother. (1996) [Pubmed]
  22. In vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicillin, cephalothin, and cefoxitin. Eley, A., Greenwood, D. Antimicrob. Agents Chemother. (1981) [Pubmed]
  23. Effect of protein binding on drug penetration into blister fluid. Shyu, W.C., Quintiliani, R., Nightingale, C.H., Dudley, M.N. Antimicrob. Agents Chemother. (1988) [Pubmed]
  24. Susceptibility of Neisseria gonorrhoeae associated with pelvic inflammatory disease to cefoxitin, ceftriaxone, clindamycin, gentamicin, doxycycline, azithromycin, and other antimicrobial agents. Rice, R.J., Knapp, J.S. Antimicrob. Agents Chemother. (1994) [Pubmed]
  25. Pharmacology of ceftizoxime compared with that of cefamandole. Neu, H.C., Srinivasan, S. Antimicrob. Agents Chemother. (1981) [Pubmed]
  26. Pharmacokinetics of ceftizoxime in animals after parenteral dosing. Murakawa, T., Sakamoto, H., Fukada, S., Nakamoto, S., Hirose, T., Itoh, N., Nishida, M. Antimicrob. Agents Chemother. (1980) [Pubmed]
  27. Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: evidence for the cooperative functioning of PBP2, PBP4, and PBP2A. Łeski, T.A., Tomasz, A. J. Bacteriol. (2005) [Pubmed]
  28. Improved detection of methicillin-resistant Staphylococcus aureus using phenyl mannitol broth containing aztreonam and ceftizoxime. Wertheim, H., Verbrugh, H.A., van Pelt, C., de Man, P., van Belkum, A., Vos, M.C. J. Clin. Microbiol. (2001) [Pubmed]
  29. Liquid chromatographic assay of ceftizoxime in sera of normal and uremic patients. McCormick, E.M., Echols, R.M., Rosano, T.G. Antimicrob. Agents Chemother. (1984) [Pubmed]
  30. Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase. Kojo, H., Nishida, M., Goto, S., Kuwahara, S. Antimicrob. Agents Chemother. (1979) [Pubmed]
  31. Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin. Fu, K.P., Neu, H.C. Antimicrob. Agents Chemother. (1980) [Pubmed]
  32. Pharmacokinetics of ceftizoxime in subjects with various degrees of renal function. Kowalsky, S.F., Echols, R.M., Venezia, A.R., Andrews, E.A. Antimicrob. Agents Chemother. (1983) [Pubmed]
  33. High-pressure liquid chromatographic assay of ceftizoxime with an anion-exchange extraction technique. Fasching, C.E., Peterson, L.R., Bettin, K.M., Gerding, D.N. Antimicrob. Agents Chemother. (1982) [Pubmed]
WikiGenes - Universities